PolitiQuote

Political speech, timestamped and in context

Robert F. Kennedy Jr.: “Mark Cuban Cause plus drug company will develop the regulatory and manufacturing processes needed to produce…”

Featuring: Robert F. Kennedy Jr., Independent | United States Secretary of Health and Human Services | National

Watch on YouTube

LIVE: HHS Sec. Robert F. Kennedy, Jr. Announces PTSD Research Investment

Published

First, HHS is committing up to 4.9 million through the Advanced Research Projects Agency for Health ARPA H to advance ibogaine treatment for PTSD. These awards will support scientific and regulatory manufacturing work necessary to prepare for future US Clinical trials. Mark Cuban Cause plus drug company will develop the regulatory and manufacturing processes needed to produce single model molecule I began hydrochloride in the United States for study for potential PTS treatments. Mark Cuban's company has agreed to cost plus contracts that are transparent. We're going to open source every aspect of this system so that we know that we're getting the … (09:43–10:00)

STATEMENT

Asserts that Mark Cuban's company will develop processes to produce ibogaine hydrochloride in the U.S. for PTSD study.

This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.


Robert F. Kennedy Jr.

See the main statements from Robert F. Kennedy Jr. in this video

Report A Transcription Error

Please report any error in the automated transcription.

About PolitiQuote

PolitiQuote is a civic library index to statements made by politicians in publicly available video records.

PolitiQuote is a service of Gigafact Foundation, a nonpartisan nonprofit advancing facts and information transparency, community by community.

Visit gigafact.org to learn more.